title: Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement.
authors: Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
authors: Hareth
authors: H
authors: Nahi
authors: Erik
authors: E
authors: Svedmyr
authors: Richard
authors: R
authors: Lerner
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D002490:Central Nervous System / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D013792:Thalidomide; D000069461:Bendamustine Hydrochloride